Brought to you by PCM Scientific, our CME division, we are excited to announce the launch of the HCM Academy 2023 programme.

Expanding on last year's pilot, the programme offers independent medical education, surrounding diagnosis and best practice care for patients with hypertrophic cardiomyopathy (HCM).

The programme will target primary and secondary care audiences including GPs, primary care nurses, cardiologists, interventional cardiologists, electrophysiologists, echocardiographers, and hospital pharmacists across the United States, Canada, and Europe, including the United Kingdom.

The HCM Academy 2023 offers free online education, designed to increase awareness and knowledge surrounding HCM. The curriculum will include three primary care and six secondary care focused webinars, with on-demand content available after the live event, and six case studies, linked to each of the secondary care webinars.  

The first primary care webinar will take place on 27 March 2023 led by Anjali Owens and Lubna Choudhury and the first secondary care webinar on 11 April 2023 led by Anjali Owens and Stefano Nistri.

Marketing of the resources will be via the HCM Academy, and our media brands, PulseNursing in PracticeHospital Healthcare Europe and Hospital Pharmacy Europe